HNMT and Alzheimer disease: Recently, enhancing histamine neurotransmission by inhibition of their catabolic enzyme HNMT has been proposed as a potential therapeutical strategy for AD patients [8], due to their effects on cognitive functions [20], neuroplasticity [21], neurogenesis [22], and the degradation of the amyloid beta (Aβ) peptide [23].